Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / LA |
profuse sweats; chills; brain fog; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of sweating in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (had shingles). Previously administered products included Acyclovir (received 5 times a day). In APR-2025, the patient received the 1st dose of Shingrix (intramuscular, left deltoid). In APR-2025, an unknown time after receiving Shingrix, the patient experienced sweating (Verbatim: profuse sweats), chills (Verbatim: chills) and brain fog (Verbatim: brain fog). The outcome of the sweating, chills and brain fog were resolved. It was unknown if the reporter considered the sweating, chills and brain fog to be related to Shingrix. It was unknown if the company considered the sweating, chills and brain fog to be related to Shingrix. Additional Information: GSK Receipt Date: 29-APR-2025 The pharmacist stating that he was procrastinated in getting the vaccine. He got shingles early on and thought he had immunity to exposure. He was treated with Acyclovir 5 times a day. He got hist first dose of Shingrix 3 weeks ago. He experienced profuse sweats, chills and brain fog that week up to 2 weeks after. Symptoms were now resolved. He states he had been told that the 2nd dose of Shingrix was worse but he felt the first dose was worse.
Medical History/Concurrent Conditions: Shingles (had shingles)